Advertisement

Amplification of Tissue Peroxides in Disease

  • William E. M. Lands
  • Robert B. Pendleton

Abstract

The fatty acid oxygenases, cyclooxygenase and lipoxygenase, require hydroperoxides to achieve maximal rates of reaction, and their reaction products are hydroperoxides that can stimulate a faster oxygenation reaction. The cyclooxygenase can be stimulated to half-maximal velocity by 20 picomoles of lipid hydroperoxide per ml (1), while it can generate nanomoles of the hydroperoxide, prostaglandin G2 (PGG2). Soybean lipoxygenase, and all other lipoxygenases, also react faster as the level of lipid hydroperoxide is amplified. Thus, intracellular amplification of lipid hydroperoxides by the fatty acid oxygenases may be closely related to high rates of formation of eicosanoids (prostaglandins and leukotrienes). This relationship has broader importance when overproduction of eicosanoids is recognized to be a common occurrence in many major pathophysiological events (2). The intracellular amplification by the fatty acid oxygenases of “triggering” levels of hydroperoxide (3) to higher levels that permit pathological rates of eicosanoid synthesis needs careful study. Intracellular levels of to 10−9to 10−7 M lipid hydroperoxide seem likely to be involved in this amplification.

Keywords

Septic Patient Lipid Hydroperoxide Surgical Intensive Care Unit Prostaglandin Biosynthesis Eicosanoid Synthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R.J. Kulmacz and W.E.M. Lands, Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins 25, 531–540 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    W.E.M. Lands, Interactions of lipid hydroperoxides with eicosanoid biosynthesis. J. Free Radicals Biol. Med. 1, 97–101 (1985).CrossRefGoogle Scholar
  3. 3.
    W.E.M. Lands and P.J. Marshall, Peroxide stimulators of prostaglandin biosynthesis. IN: Rheumatology 85, (P.M. Brooks and J.R. York, Eds.), pp. 47–50, Elsevier, New York, 1985.Google Scholar
  4. 4.
    W.E.M. Lands and A.M. Hanel, Phenolic anticyclooxygenase agents in antiinflammatory and analgesic therapy. Prostaglandins 24, 271–277 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    W.E.M. Lands, H.W. Cook and L.H. Rome, Prostaglandin biosynthesis: Consequences of oxygenase mechanism upon in vitro assays of drug effectiveness. Adv. Prost. Thromb. Res., 1, 7–17 (1976).Google Scholar
  6. 6.
    A.M. Hanel and W.E.M. Lands, Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem. Pharmacol. 31, 3307–3311 (1982).PubMedCrossRefGoogle Scholar
  7. 7.
    P.J. Marshall and W.E.M. Lands, In vitro formation of activators for prostaglandin synthesis by neutrophills and macrophages from humans and guinea pigs. J. Lab. Clin. Med. 108. 525–534 (1986).PubMedGoogle Scholar
  8. 8.
    B. Chance, H. Sies and A. Boveris, Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527–605 (1979).PubMedGoogle Scholar
  9. 9.
    P.J. Marshall, M.A. Warso and W.E.M. Lands, Selective microdetermination of lipid hydroperoxides. Anal. Biochem. 145, 192–199 (1985).PubMedCrossRefGoogle Scholar
  10. 10.
    M.A. Warso and W.E.M. Lands, Presence of lipid hydroperoxide in human plasma. J. Clin. Invest. 75, 667–671 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • William E. M. Lands
    • 1
  • Robert B. Pendleton
    • 1
  1. 1.Dept. Biological ChemistryUniv. Illinois at ChicagoChicagoUSA

Personalised recommendations